|
🐜
|
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
43 auth.
Jozefien Declercq,
Karel F. A. Van Damme,
E. De Leeuw,
B. Maes,
C. Bosteels,
S. Tavernier,
Stefanie De Buyser,
R. Colman,
M. Hites,
Gil Verschelden,
T. Fivez,
F. Moerman,
I. Demedts,
N. Dauby,
Nicolas de Schryver,
...
Elke Govaerts,
S. Vandecasteele,
J. Van Laethem,
S. Anguille,
J. V. D. van der Hilst,
B. Misset,
H. Slabbynck,
X. Wittebole,
F. Lienart,
C. Legrand,
M. Buyse,
D. Stevens,
F. Bauters,
Leen Seys,
H. Aegerter,
U. Smole,
Victor Bosteels,
L. Hoste,
L. Naesens,
F. Haerynck,
L. Vandekerckhove,
P. Depuydt,
E. Van Braeckel,
S. Rottey,
I. Peene,
C. Van Der Straeten,
F. Hulstaert,
B. Lambrecht
|
6 |
2021 |
6
🐜
|
|
🐜
|
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C
41 auth.
L. Hoste,
L. Roels,
L. Naesens,
Victor Bosteels,
S. Vanhee,
Sam Dupont,
C. Bosteels,
Robin Browaeys,
N. Vandamme,
Kevin Verstaen,
J. Roels,
Karel F. A. Van Damme,
B. Maes,
E. De Leeuw,
Jozefien Declercq,
...
H. Aegerter,
Leen Seys,
U. Smole,
Sofie De Prijck,
Manon Vanheerswynghels,
Karlien Claes,
V. Debacker,
G. Van Isterdael,
Lynn Backers,
Kathleen B. M. Claes,
P. Bastard,
E. Jouanguy,
Shen-Ying Zhang,
G. Mets,
J. Dehoorne,
Kristof Vandekerckhove,
P. Schelstraete,
J. Willems,
P. Stordeur,
S. Janssens,
R. Beyaert,
Y. Saeys,
J. Casanova,
B. Lambrecht,
F. Haerynck,
S. Tavernier
|
6 |
2021 |
6
🐜
|
|
🦁
|
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
17 auth.
B. Maes,
C. Bosteels,
E. De Leeuw,
Jozefien Declercq,
Karel F. A. Van Damme,
Anja Delporte,
Bénédicte Demeyere,
S. Vermeersch,
M. Vuylsteke,
J. Willaert,
...
L. Bollé,
Yuri Vanbiervliet,
Jana Decuypere,
Frederick Libeer,
S. Vandecasteele,
I. Peene,
B. Lambrecht
|
5 |
2020 |
5
🦁
|
|
🐜
|
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19
20 auth.
Karel F. A. Van Damme,
S. Tavernier,
N. Van Roy,
E. De Leeuw,
Jozefien Declercq,
C. Bosteels,
B. Maes,
M. De Bruyne,
D. Bogaert,
Victor Bosteels,
...
L. Hoste,
L. Naesens,
P. Maes,
A. Grifoni,
D. Weiskopf,
A. Sette,
P. Depuydt,
E. Van Braeckel,
F. Haerynck,
B. Lambrecht
|
5 |
2020 |
5
🐜
|
|
🐜
|
Epithelial HMGB1 Delays Skin Wound Healing and Drives Tumor Initiation by Priming Neutrophils for NET Formation.
24 auth.
E. Hoste,
Christian Maueröder,
L. Van Hove,
L. Catrysse,
Hanna-Kaisa Vikkula,
M. Sze,
B. Maes,
D. Karjosukarso,
L. Martens,
A. Gonçalves,
...
E. Parthoens,
R. Roelandt,
W. Declercq,
I. Fuentes,
F. Palisson,
S. González,
J. Salas-Alanis,
L. Boon,
P. Huebener,
K. Mulder,
K. Ravichandran,
Y. Saeys,
R. Schwabe,
G. van Loo
|
5 |
2019 |
5
🐜
|
|
🐜
|
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
33 auth.
C. Bosteels,
Karel F. A. Van Damme,
E. De Leeuw,
Jozefien Declercq,
B. Maes,
Victor Bosteels,
L. Hoste,
L. Naesens,
Nincy Debeuf,
J. Deckers,
B. Cole,
Marion Pardons,
D. Weiskopf,
A. Sette,
Y. V. Weygaerde,
...
T. Malfait,
S. Vandecasteele,
I. Demedts,
H. Slabbynck,
S. Allard,
P. Depuydt,
E. Van Braeckel,
J. De Clercq,
L. Martens,
S. Dupont,
R. Seurinck,
N. Vandamme,
F. Haerynck,
D. Roychowdhury,
L. Vandekerckhove,
M. Guilliams,
S. Tavernier,
B. Lambrecht
|
4 |
2022 |
4
🐜
|
|
🐜
|
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial
17 auth.
C. Bosteels,
B. Maes,
Karel F. A. Van Damme,
E. De Leeuw,
Jozefien Declercq,
Anja Delporte,
Bénédicte Demeyere,
S. Vermeersch,
M. Vuylsteke,
J. Willaert,
...
L. Bollé,
Yuri Vanbiervliet,
Jana Decuypere,
Frederick Libeer,
S. Vandecasteele,
I. Peene,
B. Lambrecht
|
4 |
2020 |
4
🐜
|
|
🐬
|
Range of motion in femoroacetabular impingement.
E. Audenaert,
J. Van Houcke,
B. Maes,
L. Vanden Bossche,
J. Victor,
C. Pattyn
|
4 |
2012 |
4
🐬
|
